Outsourcing: Analysis and developments of contract service providers to the pharmaceutical and biotechnology industries - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Outsourcing
Contract manufacturing organizations (CMOs) and contract research organizations (CROs). Global sourcing of pharma ingredients and services. Trends and challenges for the biopharmaceutical and pharmaceutical industries.

Expanding Capabilities in the Pharmaceutical Cold Chain

February 2, 2012

Pharmaceutical Technology

As biopharmaceutical development and commercialization increases, companies are expanding their cold-chain capabilities.

Sustainable Investment

February 2, 2012

Pharmaceutical Technology

Pharma announces plans for the year ahead at annual JPMorgan Global Healthcare conference.

FDA and Justice Department Address Drug Quality Concerns

February 2, 2012

Pharmaceutical Technology

More collaboration and expanded oversight aim to compel manufacturers to follow GMPs.

Strategies for Preferred-Provider Partnerships

February 1, 2012

Pharmaceutical Technology

The author examines recent examples of preferred-provider collaborations.

Outsourcing to Emerging Markets: The Effect of the European Economic Crisis

February 1, 2012

Pharmaceutical Technology

Each developing economy has unique economic, political, and cultural issues that help define its pharmaceutical market. To succeed, multinational pharmaceutical companies will have to adapt differently.

Managing the Quality Relationship for a Contractual Agreement

February 1, 2012

Pharmaceutical Technology

The author describes an equation that can be used to define the Quality relationship between a contract manufacturing organization and a client, including how to factor in both party's needs and regulatory commitments.

Evaluating Competitive Forces in Contract Manufacturing

February 1, 2012

Pharmaceutical Technology

The author examines the opportunities and positioning of contract service providers.

Case Studies in Pharmaceutical Project Management

February 1, 2012

Pharmaceutical Technology

A technical forum featuring Catalent Pharma Solutions, SAFC, and Neuland Laboratories.

Contract Services in 2012

February 1, 2012

PTSM: Pharmaceutical Technology Sourcing and Management

Some recent private-equity buyouts of CROs show both the upside and downside for investors.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
26%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
10%
All of the above.
43%
No government involvement in patient treatment or drug development.
10%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Click here